Rubric Capital Management LP
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 1687509
NEW YORK, NY
Position in HRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,920,136
-$11,117,326 QoQ
Shares Held
30,046,828
0.0% QoQ
Ownership
15.8%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1
of 161 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. HRTX ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $216,880,748 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
6,000,000 | $212,340,000 | |
| 3 | ZYME |
Zymeworks Inc.
|
7,000,000 | $182,980,000 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
7,227,778 | $175,345,894 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
9,100,000 | $122,941,000 | |
| 6 | ARDX |
Ardelyx, Inc.
|
16,202,700 | $82,633,770 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
9,339,414 | $78,170,895 | |
| 8 | MNKD |
Mannkind Corp
|
18,000,000 | $76,680,000 |
All Filings in HRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,920,136 | 30,046,828 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,037,462 | 30,046,828 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,060,876 | 30,046,828 | Shares | Sole | 2026-02-13 | |
| 2025-10-15 | $40,563,217 | 30,046,828 | Shares | Sole | 2025-10-17 | |
| 2025-09-30 | $36,666,917 | 29,100,728 | Shares | Sole | 2025-11-14 | |
| 2025-08-08 | $38,412,960 | 29,100,728 | Shares | Sole | 2025-08-12 | |
| 2025-06-30 | $55,296,951 | 26,713,503 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $58,769,706 | 26,713,503 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $40,871,659 | 26,713,503 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,159,870 | 26,713,503 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $93,497,260 | 26,713,503 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $73,996,403 | 26,713,503 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $45,412,955 | 26,713,503 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $27,514,908 | 26,713,503 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $13,630,000 | 11,750,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $17,742,500 | 11,750,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,375,000 | 11,750,000 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $10,618,904 | 2,516,328 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||